Coupling of the NMDA receptor to neuroprotective and neurodestructive events

Biochemical Society Transactions

Volumn 37, Issue 6, 2009, Pages 1147-1160

  Hardingham, Giles E ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Calcium signalling; N methyl D aspartate receptor (NMDAR); Neurodegeneration; Neuroprotection; Oxidative stress; Transcription

Indexed keywords

ANTIOXIDANT; CALPAIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CLINICAL TRIAL; DEGENERATIVE DISEASE; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIOXIDANTS; APOPTOSIS; CALPAIN; CLINICAL TRIALS AS TOPIC; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; MITOCHONDRIA; NERVE DEGENERATION; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PROTEIN ISOFORMS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 70450182118     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371147     Document Type: Article

References (136)

1. Verkhratsky, A. and Kirchhoff, F. (2007) NMDA receptors in glia. Neuroscientist 13, 28-37
2. Szczesniak, A. M., Gilbert, R. W., Mukhida, M. and Anderson, G. I. (2005) Mechanical loading modulates glutamate receptor subunit expression in bone. Bone 37, 63-73
3. Ramage, L., Martel, M. A., Hardingham, G. E. and Salter, D. M. (2008) NMDA receptor expression and activity in osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 16, 1576-1584
4. Kohr, G. (2006) NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res. 326, 439-446
5. Waxman, E. A. and Lynch, D. R. (2005) N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11, 37-49
6. Collins, M. O., Husi, H., Yu, L., Brandon, J. M., Anderson, C. N., Blackstock, W. P., Choudhary, J. S. and Grant, S. G. (2006) Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J. Neurochem. 97(Suppl. 1), 16-23
7. Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y. T., Salter, M. W. and Tymianski, M. (2002) Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298, 846-850.
8. Aamodt, S. M. and Constantine-Paton, M. (1999) The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol. 79, 133-144
9. Bliss, T. V. and Collingridge, G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39
10. Arundine, M. and Tymianski, M. (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668
11. Lipton, S. A. and Rosenberg, P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-621
12. Rossi, D. J., Oshima, T. and Attwell, D. (2000) Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321
13. Camacho, A. and Massieu, L. (2006) Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch. Med. Res. 37, 11-18
14. Choi, D. W. (1988) Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465-469
15. Ikonomidou, C. and Turski, L. (2002) Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383-386
16. Hardingham, G. E. and Bading, H. (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 26, 81-89
17. Lipton, S. A. and Nakanishi, N. (1999) Shakespeare in Love - with NMDA receptors? Nat. Med. 5, 270-271
18. Muir, K. W. (2006) Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol. 6, 53-60
19. Albers, G. W., Goldstein, L. B., Hall, D. and Lesko, L. M. (2001) Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA, J. Am. Med. Assoc. 286, 2673-2682
20. Pohl, D., Ishmaru, M. J., Bittigau, P., Stadhaus, D., Hubner, C., Olney, J. W., Turski, L. and Ikonomidou, C. (1999) NMDA antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl. Acad. Sci. U. S. A. 96, 2508-2513
21. Gould, E., Cameron, H. A. and McEwen, B. S. (1994) Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus. J. Comp. Neurol. 340, 551-565
22. Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vockler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L. and Olney, J. W. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283, 70-74
23. Monti, B. and Contestabile, A. (2000) Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum. Eur. J. Neurosci. 12, 3117-3123
24. Adams, S. M., De Rivero Vaccari, J. C. and Corriveau, R. A. (2004) Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J. Neurosci. 24, 9441-9450
25. Ikonomidou, C., Stefovska, V. and Turski, L. (2000) Neuronal death enhanced by N-methyl-d-aspartate antagonists. Proc. Natl. Acad. Sci. U. S. A. 97, 12885-12890
26. Tashiro, A., Sandler, V. M., Toni, N., Zhao, C. and Gage, F. H. (2006) NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus. Nature 442, 929-933
27. Hetman, M. and Kharebava, G. (2006) Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787-799
28. Hardingham, G. E., Arnold, F. J. and Bading, H. (2001) Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat. Neurosci. 4, 261-267
29. Papadia, S., Stevenson, P., Hardingham, N. R., Bading, H. and Hardingham, G. E. (2005) Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J. Neurosci. 25, 4279-4287
30. Lafon-Cazal, M., Perez, V., Bockaert, J. and Marin, P. (2002) Akt mediates the anti-apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells. Eur. J. Neurosci. 16, 575-583
31. Joyal, J. L., Burks, D. J., Pons, S., Matter, W. F., Vlahos, C. J., White, M. F. and Sacks, D. B. (1997) Calmodulin activates phosphatidylinositol 3-kinase. J. Biol. Chem. 272, 28183-28186
32. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bá. Curr. Biol. 7, 261-269
33. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
34. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
35. Soriano, F. X., Papadia, S., Hofmann, F., Hardingham, N. R., Bading, H. and Hardingham, G. E. (2006) Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26, 4509-4518
36. Downward, J. (1999) How BAD phosphorylation is good for survival. Nat. Cell Biol. 1, E33-E35
37. Kim, A. H., Khursigara, G., Sun, X., Franke, T. F. and Chao, M. V. (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21, 893-901
38. Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M. P., Mitsuda, N. and Tohyama, M. (2001) Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276, 5256-5264
39. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868
40. Gilley, J., Coffer, P. J. and Ham, J. (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162, 613-622
41. Papadia, S., Soriano, F. X., Leveille, F., Martel, M. A., Dakin, K. A., Hansen, H. H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V. et al. (2008) Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476-487
42. Lipton, S. A. (2008) NMDA receptor activity regulates transcription of antioxidant pathways. Nat. Neurosci. 11, 381-382
43. Al-Mubarak, B., Soriano, F. X. and Hardingham, G. E. (2009) Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels 3, 233-238
44. Lau, D. and Bading, H. (2009) Synaptic activity-mediated suppression of p53 and induction of nuclear calcium-regulated neuroprotective genes promote survival through inhibition of mitochondrial permeability transition. J. Neurosci. 29, 4420-4429
45. Lonze, B. E. and Ginty, D. D. (2002) Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623
46. Hardingham, G. E., Fukunaga, Y. and Bading, H. (2002) Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414
47. Hardingham, G. E., Arnold, F. J. and Bading, H. (2001) A calcium microdomain near NMDA receptors: on switch for ERKdependent synapse-to-nucleus communication. Nat. Neurosci. 4, 565-566
48. Wu, G. Y., Deisseroth, K. and Tsien, R. W. (2001) Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. U. S. A. 98, 2808-2813
49. Hardingham, G. E., Chawla, S., Cruzalegui, F. H. and Bading, H. (1999) Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels. Neuron 22, 789-798
50. Impey, S., Fong, A. L., Wang, Y., Cardinaux, J. R., Fass, D. M., Obrietan, K., Wayman, G. A., Storm, D. R., Soderling, T. R. and Goodman, R. H. (2002) Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34, 235-244
51. Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, 3rd, J. R., Takemori, H. et al. (2004) The CREB coactivator TORC2 functions as a calcium-and cAMP-sensitive coincidence detector. Cell 119, 61-74
52. Kovacs, K. A., Steullet, P., Steinmann, M., Do, K. Q., Magistretti, P. J., Halfon, O. and Cardinaux, J. R. (2007) TORC1 is a calcium-and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 104, 4700-4705
53. Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A. and Ginty, D. D. (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358-2361
54. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A. and Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and-independent mechanisms. Science 286, 1358-1362
55. Walton, M., Woodgate, A. M., Muravlev, A., Xu, R., During, M. J. and Dragunow, M. (1999) CREB phosphorylation promotes nerve cell survival. J. Neurochem. 73, 1836-1842
56. Lonze, B. E., Riccio, A., Cohen, S. and Ginty, D. D. (2002) Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34, 371-385
57. Mantamadiotis, T., Lemberger, T., Bleckmann, S. C., Kern, H., Kretz, O., Villalba, A. M., Tronche, F., Kellendonk, C., Gau, D., Kapfhammer, J. et al. (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet. 31, 47-54
58. Deisseroth, K., Heist, E. K. and Tsien, R. W. (1998) Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392, 198-202
59. Hardingham, G. E., Chawla, S., Johnson, C. M. and Bading, H. (1997) Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385, 260-265
60. Limback-Stokin, K., Korzus, E., Nagaoka-Yasuda, R. and Mayford, M. (2004) Nuclear calcium/calmodulin regulates memory consolidation. J. Neurosci. 24, 10858-10867
61. Lee, B., Butcher, G. Q., Hoyt, K. R., Impey, S. and Obrietan, K. (2005) Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133. J. Neurosci. 25, 1137-1148
62. Jaworski, J., Mioduszewska, B., Sanchez-Capelo, A., Figiel, I., Habas, A., Gozdz, A., Proszynski, T., Hetman, M., Mallet, J. and Kaczmarek, L. (2003) Inducible cAMP early repressor, an endogenous antagonist of cAMP responsive element-binding protein, evokes neuronal apoptosis in vitro. J. Neurosci. 23, 4519-4526
63. Mabuchi, T., Kitagawa, K., Kuwabara, K., Takasawa, K., Ohtsuki, T., Xia, Z., Storm, D., Yanagihara, T., Hori, M. and Matsumoto, M. (2001) Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J. Neurosci. 21, 9204-9213
64. Walton, M. R. and Dragunow, M. (2000) Is CREB a key to neuronal survival? Trends Neurosci. 23, 48-53
65. Impey, S., McCorkle, S. R., Cha-Molstad, H., Dwyer, J. M., Yochum, G. S., Boss, J. M., McWeeney, S., Dunn, J. J., Mandel, G. and Goodman, R. H. (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041-1054
66. Mayr, B. and Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609
67. Zhang, X., Odom, D. T., Koo, S. H., Conkright, M. D., Canettieri, G., Best, J., Chen, H., Jenner, R., Herbolsheimer, E., Jacobsen, E. et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. U. S. A. 102, 4459-4464
68. Zhang, S. J., Steijaert, M. N., Lau, D., Schutz, G., Delucinge-Vivier, C., Descombes, P. and Bading, H. (2007) Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53, 549-562
69. Shieh, P. B., Hu, S. C., Bobb, K., Timmusk, T. and Ghosh, A. (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727-740
70. Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J. and Greenberg, M. E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726
71. Hansen, H. H., Briem, T., Dzietko, M., Sifringer, M., Voss, A., Rzeski, W., Zdzisinska, B., Thor, F., Heumann, R., Stepulak, A. et al. (2004) Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol. Dis. 16, 440-453
72. Mariani, E., Polidori, M. C., Cherubini, A. and Mecocci, P. (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 827, 65-75
73. Halliwell, B. (2006) Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 1634-1658
74. Yoshida, T., Nakamura, H., Masutani, H. and Yodoi, J. (2005) The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann. N. Y. Acad. Sci. 1055, 1-12
75. Biteau, B., Labarre, J. and Toledano, M. B. (2003) ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425, 980-984
76. Chang, T. S., Jeong, W., Woo, H. A., Lee, S. M., Park, S. and Rhee, S. G. (2004) Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 50994-51001
77. Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V. and Chumakov, P. M. (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600
78. Soriano, F. X., Leveille, F., Papadia, S., Higgins, L. G., Varley, J., Baxter, P., Hayes, J. D. and Hardingham, G. E. (2008) Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1, 2-dithiole-3-thione. J. Neurochem. 107, 533-543
79. Woo, H. A., Bae, S. H., Park, S. and Rhee, S. G. (2009) Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins. Antioxid. Redox Signaling 11, 739-745
80. Olney, J. W. (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721
81. Choi, D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276
82. Lipton, S. A. (2006) Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5, 160-170
83. Kalia, L. V., Kalia, S. K. and Salter, M. W. (2008) NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 7, 742-755
84. Stout, A. K., Raphael, H. M., Kanterewicz, B. I., Klann, E. and Reynolds, I. J. (1998) Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1, 366-373
85. Nicholls, D. G., Johnson-Cadwell, L., Vesce, S., Jekabsons, M. and Yadava, N. (2007) Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J. Neurosci. Res. 85, 3206-3212
86. Vesce, S., Kirk, L. and Nicholls, D. G. (2004) Relationships between superoxide levels and delayed calcium deregulation in cultured cerebellar granule cells exposed continuously to glutamate. J. Neurochem. 90, 683-693
87. Nicholls, D. G. (2008) Oxidative stress and energy crises in neuronal dysfunction. Ann. N. Y. Acad. Sci. 1147, 53-60
88. Brennan, A. M., Suh, S. W., Won, S. J., Narasimhan, P., Kauppinen, T. M., Lee, H., Edling, Y., Chan, P. H. and Swanson, R. A. (2009) NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 12, 857-863
89. Forder, J. P. and Tymianski, M. (2009) Postsynaptic mechanisms of excitotoxicity: involvement of postsynaptic density proteins, radicals, and oxidant molecules. Neuroscience 158, 293-300
90. Kauppinen, T. M. and Swanson, R. A. (2007) The role of poly (ADP-ribose) polymerase-1 in CNS disease. Neuroscience 145, 1267-1272
91. Andrabi, S. A., Dawson, T. M. and Dawson, V. L. (2008) Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann. N. Y. Acad. Sci. 1147, 233-241
92. Aarts, M., Iihara, K., Wei, W. L., Xiong, Z. G., Arundine, M., Cerwinski, W., MacDonald, J. F. and Tymianski, M. (2003) A key role for TRPM7 channels in anoxic neuronal death. Cell 115, 863-877
93. Bano, D., Young, K. W., Guerin, C. J., Lefeuvre, R., Rothwell, N. J., Naldini, L., Rizzuto, R., Carafoli, E. and Nicotera, P. (2005) Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120, 275-285
94. Pottorf, 2nd, W. J., Johanns, T. M., Derrington, S. M., Strehler, E. E., Enyedi, A. and Thayer, S. A. (2006) Glutamate-induced protease-mediated loss of plasma membrane Ca2+ pump activity in rat hippocampal neurons. J. Neurochem. 98, 1646-1656
95. Schwab, B. L., Guerini, D., Didszun, C., Bano, D., Ferrando-May, E., Fava, E., Tam, J., Xu, D., Xanthoudakis, S., Nicholson, D. W. et al. (2002) Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ. 9, 818-831
96. Xu, W., Wong, T. P., Chery, N., Gaertner, T., Wang, Y. T. and Baudry, M. (2007) Calpain-mediated mGluR1á truncation: a key step in excitotoxicity. Neuron 53, 399-412
97. Xu, J., Kurup, P., Zhang, Y., Goebel-Goody, S. M., Wu, P. H., Hawasli, A. H., Baum, M. L., Bibb, J. A. and Lombroso, P. J. (2009) Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J. Neurosci. 29, 9330-9343
98. Kawasaki, H., Morooka, T., Shimohama, S., Kimura, J., Hirano, T., Gotoh, Y. and Nishida, E. (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J. Biol. Chem. 272, 18518-18521
99. Legos, J. J., McLaughlin, B., Skaper, S. D., Strijbos, P. J., Parsons, A. A., Aizenman, E., Herin, G. A., Barone, F. C. and Erhardt, J. A. (2002) The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. Eur. J. Pharmacol. 447, 37-42
100. Cao, J., Semenova, M. M., Solovyan, V. T., Han, J., Coffey, E. T. and Courtney, M. J. (2004) Distinct requirements for p38á and c-Jun. N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279, 35903-35913
101. Borsello, T., Clarke, P. G., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J. and Bonny, C. (2003) A peptide inhibitor of c-Jun. N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180-1186
102. Soriano, F. X., Martel, M. A., Papadia, S., Vaslin, A., Baxter, P., Rickman, C., Forder, J., Tymianski, M., Duncan, R., Aarts, M. et al. (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci. 28, 10696-10710
103. Semenova, M. M., Maki-Hokkonen, A. M., Cao, J., Komarovski, V., Forsberg, K. M., Koistinaho, M., Coffey, E. T. and Courtney, M. J. (2007) Rho mediates calcium-dependent activation of p38á and subsequent excitotoxic cell death. Nat. Neurosci. 10, 436-443
104. Cao, J., Viholainen, J. I., Dart, C., Warwick, H. K., Leyland, M. L. and Courtney, M. J. (2005) The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126
105. Martel, M. A., Soriano, F. X., Baxter, P., Rickman, C., Duncan, R., Wyllie, D. J. and Hardingham, G. E. (2009) Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression. Channels 3, 12-15
106. Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. and Murphy, M. P. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596
107. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A. and Nicotera, P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973
108. Tompa, P., Baki, A., Schad, E. and Friedrich, P. (1996) The calpain cascade: μ-calpain activates m-calpain. J. Biol. Chem. 271, 33161-33164
109. Nicholls, D. G. (2004) Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr. Mol. Med. 4, 149-177
110. Rameau, G. A., Tukey, D. S., Garcin-Hosfield, E. D., Titcombe, R. F., Misra, C., Khatri, L., Getzoff, E. D. and Ziff, E. B. (2007) Biphasic coupling of neuronal nitric oxide synthase phosphorylation to the NMDA receptor regulates AMPA receptor trafficking and neuronal cell death. J. Neurosci. 27, 3445-3455
111. Leveille, F., El Gaamouch, F., Gouix, E., Lecocq, M., Lobner, D., Nicole, O. and Buisson, A. (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 4258-4271
112. Hardingham, G. E. and Bading, H. (2002) Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated. Biochim. Biophys. Acta 1600, 148-153
113. Sala, C., Rudolph-Correia, S. and Sheng, M. (2000) Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J. Neurosci. 20, 3529-3536
114. Ivanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben-Ari, Y. and Medina, I. (2006) Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the ERK activity in cultured rat hippocampal neurons. J. Physiol. 572, 789-798
115. Balazs, R., Hack, N. and Jorgensen, O. S. (1988) Stimulation of the N-methyl-d-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci. Lett. 87, 80-86
116. Bambrick, L. L., Yarowsky, P. J. and Krueger, B. K. (1995) Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse. Proc. Natl. Acad. Sci. U. S. A. 92, 9692-9696
117. Chuang, D. M., Gao, X. M. and Paul, S. M. (1992) N-methyl-d-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. Mol. Pharmacol. 42, 210-216
118. Rocha, M., Martins, R. A. and Linden, R. (1999) Activation of NMDA receptors protects against glutamate neurotoxicity in the retina: evidence for the involvement of neurotrophins. Brain Res. 827, 79-92
119. Raval, A. P., Dave, K. R., Mochly-Rosen, D., Sick, T. J. and Perez-Pinzon, M. A. (2003) å PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J. Neurosci. 23, 384-391
120. Monti, B., Marri, L. and Contestabile, A. (2002) NMDA receptor-dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development. Eur. J. Neurosci. 16, 1490-1498
121. Jiang, X., Tian, F., Mearow, K., Okagaki, P., Lipsky, R. H. and Marini, A. M. (2005) The excitoprotective effect of N-methyl-d-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94, 713-722
122. Dieterich, D. C., Karpova, A., Mikhaylova, M., Zdobnova, I., Konig, I., Landwehr, M., Kreutz, M., Smalla, K. H., Richter, K., Landgraf, P. et al. (2008) Caldendrin-Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. PLoS Biol. 6, e34
123. Gouix, E., Leveille, F., Nicole, O., Melon, C., Had-Aissouni, L. and Buisson, A. (2009) Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation. Mol. Cell. Neurosci. 40, 463-473
124. Wahl, A. S., Buchthal, B., Rode, F., Bomholt, S. F., Freitag, H. E., Hardingham, G. E., Ronn, L. C. and Bading, H. (2009) Hypoxic/ischemic conditions induce expression of the putative pro-death gene Clca1 via activation of extrasynaptic N-methyl-d-aspartate receptors. Neuroscience 158, 344-352
125. Hossmann, K.-A. (1994) Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36, 557-565
126. Lee, J.-M., Zipfel, G. J. and Choi, D. W. (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7-A14
127. Dirnagl, U., Iadecola, C. and Moskowitz, M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397
128. Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M. and Wang, Y. T. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857
129. Kim, E. and Sheng, M. (2004) PDZ domain proteins of synapses. Nat. Rev. Neurosci. 5, 771-781
130. Neyton, J. and Paoletti, P. (2006) Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. J. Neurosci. 26, 1331-1333
131. Frizelle, P. A., Chen, P. E. and Wyllie, D. J. A. (2006) Equilibrium constants for NVP-AAM077 acting at recombinant NR1/NR2A and NR1/NR2B NMDA receptors: implications for studies of synaptic transmission. Mol. Pharmacol. 70, 1022-1032
132. Auberson, Y. P., Allgeier, H., Bischoff, S., Lingenhoehl, K., Moretti, R. and Schmutz, M. (2002) 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 12, 1099-1102
133. Von Engelhardt, J., Coserea, I., Pawlak, V., Fuchs, E. C., Kohr, G., Seeburg, P. H. and Monyer, H. (2007) Excitotoxicity in vitro by NR2Aand NR2B-containing NMDA receptors. Neuropharmacology 53, 10-17
134. Martel, M., Wyllie, D. J. and Hardingham, G. E. (2009) In developing hippocampal neurons, NR2B-containing NMDA receptors can mediate signalling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience 158, 334-343
135. Olney, J. W., Wozniak, D. F., Jevtovic-Todorovic, V., Barber, N., Bittigau, P. and Ikonomidou, C. (2002) Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 12, 488-498
136. Lipton, S. A. (2007) Pathologically activated therapeutics for neuroprotection. Nat. Rev. Neurosci. 8, 803-808